Sponsor Pipeline

ModeX Therapeutics, An OPKO Health Company Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
10
Disease Areas
Active Trials by Phase
Phase 1/2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07110584 Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors Advanced Tumors Recruiting
NCT07249905 Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of… Lymphoma Recruiting
NCT06239194 Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors Biliary Tract Cancer Recruiting
Phase 1
NCT07445971 A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe… COVID -19 Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Prostate Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1) Gastric Cancer (1) Kidney Cancer (1) Cervical Cancer (1) Endometrial Cancer (1)
Get alerts when ModeX Therapeutics, An OPKO Health Company's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free